Form 4: Precigen Director Cesar L. Alvarez Acquires Shares and Stock Units

Director Cesar L. Alvarez reports acquisition of Precigen shares and restricted stock units.

Summary

• On March 14, 2024, Cesar L. Alvarez, a director of Precigen, Inc., acquired 43,706 shares of common stock at a price of $1.43 per share.
• These shares were issued in lieu of an annual retainer of $62,500.
• Following this transaction, Alvarez directly owns 569,933 shares of Precigen common stock.
• Alvarez also acquired 87,412 restricted stock units (RSUs), each representing a contingent right to receive one share of Precigen common stock, which vest in full on March 14, 2025.
• Additionally, Alvarez acquired an option to purchase 101,626 shares of common stock at an exercise price of $1.43, expiring on March 14, 2034.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider transactions. The acquisition of shares by a director could be seen as a positive signal, but it's also part of their compensation.

Positives

• Director's acquisition of shares may signal confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their holdings in the company's stock.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates